Evolent Health
EVH
61 hedge funds and large institutions have $288M invested in Evolent Health in 2015 Q2 according to their latest regulatory filings, with 61 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
37.09% more ownership
Funds ownership: 0% → 37.09% (+37%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
+$44.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$27.3M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$26.6M |
| 4 |
JP Morgan Chase
New York
|
+$16.9M |
| 5 |
Goldman Sachs
New York
|
+$14.7M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Bank of Montreal
Toronto,
Ontario, Canada
| $195K | +$186K | +10,000 | New |
|
52
BlackRock
New York
| $123K | +$117K | +6,300 | New |
|
|
WBC
53
Westpac Banking Corp
Sydney,
Australia
| $112K | +$107K | +5,744 | New |
|
|
LTFS
54
Ladenburg Thalmann Financial Services
Miami,
Florida
| $39K | +$37.3K | +2,000 | New |
|
|
MWP
55
MYCIO Wealth Partners
Philadelphia,
Pennsylvania
| $39K | +$37.3K | +2,000 | New |
|
56
US Bancorp
Minneapolis,
Minnesota
| $36K | +$34.9K | +1,870 | New |
|
|
MCM
57
Mazama Capital Management
Portland,
Oregon
| $35K | +$33.1K | +1,777 | New |
|
|
FANJ
58
Financial Architects (New Jersey)
Marlton,
New Jersey
| $20K | +$18.6K | +1,000 | New |
|
|
TRCT
59
Tower Research Capital (TRC)
New York
| $20K | +$18.6K | +1,000 | New |
|
60
Citigroup
New York
| $10K | +$9.32K | +500 | New |
|
61
UBS Group
Zurich,
Switzerland
| $9K | +$8.98K | +482 | New |
|
|
CPIG
62
Chicago Partners Investment Group
Chicago,
Illinois
| $6K | +$5.59K | +300 | New |
|
EVH Hedge Fund Activity: Q2 2015 in Review
61 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q2 2015, worth a combined $288M.
Buyers outnumbered sellers: 61 funds opened new EVH positions and 0 closed out — a net gain of 61 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was TPG Group Holdings (SBS) Advisors, opening a new position worth an estimated $44.5M.
- 61 institutional investors held Evolent Health (EVH) as of Q2 2015, up from 0 in Q1 2015.
- Funds reported $288M of Evolent Health stock for Q2 2015.
- 61 funds opened new Evolent Health positions in Q2 2015 and 0 closed out, a net change of +61 holders.
- The largest Evolent Health buyer in Q2 2015 was TPG Group Holdings (SBS) Advisors, an estimated $44.5M added.
Based on aggregated 13F filings for Q2 2015.